UPC APP 7184/2024
—·EP3646825: A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieSonstige prozessuale
- Parteien
- KlägerVertreter: Emmanuel Larere (Cabinet Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Cabinet Gide Loyrette Nouel AARPI)BeklagteVertreter: Boris Kreye (Bird & Bird LLP); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP)
- Division
- Paris CD
- Richter
- —
- Technology
- Pharmaceutical & Medical
- Sprache
- —
- Erste Entscheidung
- 27. Feb. 2024
- Letzte Entscheidung
- 28. Feb. 2024
- 2024-02-28Generic application
The Paris Central Division issued a procedural order in a revocation action concerning EP3646825 (Edwards Lifesciences v Meril Italy), addressing a request by Meril to allow a subsequent amendment to the patent by Edwards, in the context of compliance with R.30 RoP requirements for patent amendment applications.
Rechtsfragen:Subsequent amendment to patent application (R.30 RoP)Admissibility of request to amend patentAmendment of case (R.263 RoP) - 2024-02-27Generic application
The Paris Central Division ruled on Meril Italy's application to refuse admission of Edwards Lifesciences' subsequent request to amend patent EP 3 646 825, addressing the admissibility of post-deadline patent amendment requests under R.30(2) RoP.
Rechtsfragen:admissibility of subsequent patent amendment request R.30(2) RoPleave to amend case R.263 RoP - 2024-02-27Generic application
The Paris Central Division ruled on Meril Italy's application to refuse admission of Edwards Lifesciences' subsequent request to amend patent EP 3 646 825, addressing the admissibility of post-deadline patent amendment requests under R.30(2) RoP.
Rechtsfragen:admissibility of subsequent patent amendment request R.30(2) RoPleave to amend case R.263 RoP
- 2024-02-27%20CD%20Paris%20UPC_CFI_255-2023%20ORD_7283-2024%20App_7184-2024%20anonymized%20%281%29.pdf2024-02-27EN
- 2024-02-27%20CD%20Paris%20UPC_CFI_255-2023%20ORD_7283-2024%20App_7184-2024%20anonymized.pdf2024-02-27EN
- 3E509F6CA88E0F9BF9D2C0021F547EAE_en.pdf2024-02-28EN